BarlamTFCosgroveSEAbboLM, et al. Executive summary: implementing an Antibiotic Stewardship Program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:1197-1202. doi:10.1093/cid/ciw217
2.
LiuYQLorEJacobsonM.Pharmacist-directed program for monitoring foscarnet therapy. Am J Hosp Pharm. 1994;51:2155-2157. doi:10.1093/ajhp/51.17.2155
DerayGMartinezFKatlamaC, et al. Foscarnet nephrotoxicity: mechanism, incidence and prevention. Am J Nephrol. 1989;9:316-321. doi:10.1159/000167987
5.
AveryRKArav-BogerRMarrKA, et al. Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection. Transplantation. 2016;100:e74-e80. doi:10.1097/TP.0000000000001418
